{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:13:00Z","timestamp":1778562780692,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) has become as a metabolic disorder posing a significant threat to public health, with no presently available effective treatment. Circulating insulin degradation constitutes a pivotal process regulating insulin concentration and biological activity in the bloodstream, and its capacity is closely associated with hyperinsulinaemia and hepatic lipid accumulation. Hepatic lipid accumulation represents a key pathophysiological mechanism in NAFLD. Therefore, targeting the circulating insulin degradation pathway may represent a significant therapeutic opportunity for NAFLD. This study employed a multi-omics strategy, incorporating pertinent datasets from the Gene Expression Omnibus (GEO) collection, to investigate the function of circulating insulin degradation in NAFLD. We employed systems biology informatics approaches, including weighted gene co-expression network analysis (WGCNA) and machine learning models, to identify four hub biomarkers: MYO7A, AGTR1, IL1RN, and IGFBP2. We applied Shapley Additive Explanations (SHAP) to interpret the contribution of each gene to the machine learning model. The expression patterns and potential relevance of these hub genes were further assessed in external datasets, cellular models, and animal models. Overall, this hypothesis-generating study identified four candidate genes potentially associated with NAFLD and provided additional insights into the molecular mechanisms underlying disease progression.<\/jats:p>","DOI":"10.3389\/fendo.2026.1774997","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:30:05Z","timestamp":1778560205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of candidate biomarkers for NAFLD through bioinformatics analysis and machine learning based on circulating insulin degradation-associated genes"],"prefix":"10.3389","volume":"17","author":[{"given":"Mingjie","family":"Guo","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lou","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxin","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyu","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliang","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Huaihe Hospital (Zhongzhou Laboratory for Integrative Biology), Henan University","place":["Kaifeng, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95288","article-title":"Emerging perspectives in the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review","volume":"17","author":"Djeagou","year":"2025","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00275-3","article-title":"Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease","volume":"9","author":"Thomas","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2017.12.003","article-title":"Role of fatty liver in the association between obesity and reduced hepatic insulin clearance","volume":"44","author":"Matsubayashi","year":"2018","journal-title":"Diabetes Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154776","article-title":"Determinants of hepatic insulin clearance - results from a Mendelian randomization study","volume":"119","author":"Lamprinou","year":"2021","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2020.10.016","article-title":"The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes","volume":"55","author":"Guerra","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16596","DOI":"10.1038\/s41598-025-86397-x","article-title":"Identification of potential metabolic biomarkers and immune cell infiltration for metabolic associated steatohepatitis by bioinformatics analysis and machine learning","volume":"15","author":"Xie","year":"2025","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1335112","article-title":"Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2020.01.001","article-title":"LncRNAs related key pathways and genes in ischemic stroke by weighted gene co-expression network analysis (WGCNA)","volume":"112","author":"Wang","year":"2020","journal-title":"Genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3892\/etm.2018.6965","article-title":"Identification of candidate target genes for endometrial cancer, such as ANO1, using weighted gene co-expression network analysis","volume":"17","author":"Wang","year":"2019","journal-title":"Exp Ther Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38608","article-title":"ANXA3 as a novel biomarker for sepsis diagnosis: evidence from integrative WGCNA analysis","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jenvman.2025.125708","article-title":"Exploring the toxicological impact of bisphenol a exposure on psoriasis through network toxicology, machine learning, and multi-dimensional bioinformatics analysis","volume":"385","author":"Feng","year":"2025","journal-title":"J Environ Manage"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae628","article-title":"Comprehensive bioinformatics and machine learning analyses for breast cancer staging using TCGA dataset","volume":"26","author":"Das","year":"2024","journal-title":"Brief Bioinform"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2023.105049","article-title":"Machine learning prediction models and nomogram to predict the risk of in-hospital death for severe DKA: a clinical study based on MIMIC-IV, eICU databases, and a college hospital ICU","volume":"174","author":"Xie","year":"2023","journal-title":"Int J Med Inform"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf"},{"key":"B24","article-title":"A unified approach to interpreting model predictions","volume-title":"Adv Neural Inf Proces Syst","author":"Lundberg","year":"2017"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"Gomez-Lechon","year":"2007","journal-title":"Chem Biol Interact"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.07.003","article-title":"Obesity, insulin resistance, NASH and hepatocellular carcinoma","volume":"23","author":"Yu","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.02.051","article-title":"Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-1267","article-title":"Reduced insulin clearance differently relates to increased liver lipid content and worse glycemic control in recent-onset type 2 and type 1 diabetes","volume":"46","author":"Zaharia","year":"2023","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-031622-043133","article-title":"Insulin clearance in health and disease","volume":"85","author":"Najjar","year":"2023","journal-title":"Annu Rev Physiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1152\/physiol.00048.2018","article-title":"Hepatic insulin clearance: mechanism and physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiol (Bethesda)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45110570","article-title":"The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease-the transition from an adipocentric to liver-centric approach","volume":"45","author":"Veskovic","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102026","article-title":"IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFR-STAT3 pathway","volume":"89","author":"Zhai","year":"2024","journal-title":"Mol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117997","article-title":"IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease","volume":"256","author":"Xiao","year":"2020","journal-title":"Life Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1161","article-title":"Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study","volume":"32","author":"Herder","year":"2009","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J Hepatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis","volume":"45","author":"Hirose","year":"2007","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s10620-006-9133-1","article-title":"Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis","volume":"52","author":"Tox","year":"2007","journal-title":"Dig Dis Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4876-09.2009","article-title":"A novel allele of myosin VIIa reveals a critical function for the C-terminal FERM domain for melanosome transport in retinal pigment epithelial cells","volume":"29","author":"Schwander","year":"2009","journal-title":"J Neurosci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr155","article-title":"The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65","volume":"20","author":"Lopes","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J Hepatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2022.11.001","article-title":"Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis","volume":"6","author":"Magee","year":"2022","journal-title":"Liver Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1774997\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:30:06Z","timestamp":1778560206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1774997\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":44,"alternative-id":["10.3389\/fendo.2026.1774997"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1774997","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"article-number":"1774997"}}